Stock since the trade +5.0% · S&P 500 +4.8% · to Oct 5
The boss of Edwards Lifesciences sold $245K of Edwards Lifesciences shares. Nobody planned it ahead of time.
Loading…
Bernard J Zovighian is CEO at Edwards Lifesciences. OQRO lists 35 transactions filed with the SEC under this name, the latest on Jul 27, 2026, each linked to the official Form 4.
CEO
Disclosures on record
35
Companies involved
1
Stock since the trade +5.0% · S&P 500 +4.8% · to Oct 5
The boss of Edwards Lifesciences sold $245K of Edwards Lifesciences shares. Nobody planned it ahead of time.
Gift or transfer — classified separately from trades.
Gift or transfer — classified separately from trades.
CEO sold ~$46K of Edwards Lifesciences
Scheduled in advanceCEO sold ~$2.77M of Edwards Lifesciences
Scheduled in advanceCEO sold ~$66K of Edwards Lifesciences
Scheduled in advanceCompensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Gift or transfer — classified separately from trades.
Gift or transfer — classified separately from trades.
Gift or transfer — classified separately from trades.
Gift or transfer — classified separately from trades.
Gift or transfer — classified separately from trades.
Gift or transfer — classified separately from trades.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Gift or transfer — classified separately from trades.
Gift or transfer — classified separately from trades.
Routine share withholding; mechanical by default.
Stock since the trade +14.1% · S&P 500 +13.7% · to Oct 5
The boss of Edwards Lifesciences sold $1.52M of Edwards Lifesciences shares. Nobody planned it ahead of time.
Stock since the trade +14.1% · S&P 500 +13.7% · to Oct 5
The boss of Edwards Lifesciences sold $195K of Edwards Lifesciences shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Gift or transfer — classified separately from trades.
Gift or transfer — classified separately from trades.
CEO sold ~$1.83M of Edwards Lifesciences
Scheduled in advanceCEO sold ~$322K of Edwards Lifesciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Gift or transfer — classified separately from trades.
Gift or transfer — classified separately from trades.